Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Cancer Drug Resistance
All Journals
Search Log In
Editor-in-Chief: Godefridus J. Peters
Indexing: ESCI, PMC, Scopus, CAS, CNKI, Dimensions, Lens, Embase,
Journal Rank: Impact Factor 2023: 4.6 - Q1 (ONCOLOGY); CiteScore 2023: 6.6 - Q1 [Pharmacology(medical)]
Submission to first decision: 63 days
Home Articles Special Issues Volumes Webinars Videos
Cancer Drug Resistance
Search Submit
Editor-in-Chief: Godefridus J. Peters
Journal Rank: Impact Factor 2023: 4.6 - Q1 (ONCOLOGY); CiteScore 2023: 6.6 - Q1 [Pharmacology(medical)]
Submission to first decision: 63 days
Home Articles Special Issues Volumes Webinars Videos

Cancer Drug Resistance

Mitochondria in colorectal cancer stem cells - a target in drug resistance

Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma

P-glycoprotein (ABCB1) - weak dipolar interactions provide the key to understanding allocrite recognition, binding, and transport

Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance

Targeting regulated cell death pathways in acute myeloid leukemia

Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]

NaN

Articles

Most Recent | Most Viewed | Most Downloaded

Fra-1 affects chemotherapy sensitivity by inhibiting ferroptosis in gastric cancer cells

Feng Zeng, ... Yanhong Zhou
Open Access Original Article DOI: 10.20517/cdr.2024.101 15 Nov 2024
Views: Downloads:
Download PDF

The role and clinical applications of exosomes in cancer drug resistance

Wenxuan Pan, ... Minfeng Chen
Open Access Review DOI: 10.20517/cdr.2024.97 3 Nov 2024
Views: Downloads:
Download PDF

Exploring resistance to immune checkpoint inhibitors and targeted therapies in melanoma

Anum Jalil, ... Jane Mattei
Open Access Review DOI: 10.20517/cdr.2024.54 30 Oct 2024
Views: Downloads:
Download PDF

NFE2L2 and ferroptosis resistance in cancer therapy

Daolin TangDaolin Tang, Rui Kang
Open Access Review DOI: 10.20517/cdr.2024.123 24 Oct 2024
Views: Downloads:
Download PDF

The BET inhibitor sensitivity is associated with the expression level of CDC25B in pancreatic cancer models

Aubrey L. Miller, ... Karina J. YoonKarina J. Yoon
Open Access Original Article DOI: 10.20517/cdr.2024.53 17 Oct 2024
Views: Downloads:
Download PDF

Venetoclax resistance: mechanistic insights and future strategies

Faustine Ong, ... Marina Y. Konopleva
Open Access Review DOI: 10.20517/cdr.2021.125 5 May 2022
Views: Downloads:
Download PDF

Improving HER2 testing reproducibility in HER2-low breast cancer

Elham Sajjadi, ... Nicola FuscoNicola Fusco
Open Access Opinion DOI: 10.20517/cdr.2022.29 31 Aug 2022
Views: Downloads:
Download PDF

Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces

Ahmad R. Safa
Open Access Review DOI: 10.20517/cdr.2022.20 1 Aug 2022
Views: Downloads:
Download PDF

Topic: Innovative Strategies for Overcoming Multidrug Resistance in Breast Cancer

Prof. Kenneth Kin Wah To; Dr. Suresh V. Ambudkar

Submission Deadline: 20 Apr 2025

Published articles: 0

Topic: Exosomes in Combating Cancer Drug Resistance

Dr. Farrukh Aqil; Dr. Ramesh Gupta

Submission Deadline: 15 Apr 2025

Published articles: 0

For Reviewers

Peer Review Guidelines
For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Themed Collections
Resistance
Drug delivery
Nanomedicine
Tumor microenvironment
Immune checkpoint inhibitors
Target therapy
Immunotherapy
Radiotherapy
Ferroptosis
PARP inhibitors
MYC
ABC transporters
Autophagy
Metabolism
Mechanisms
Precision medicine
Extracellular vesicles
Stem cell
Biomarker
Ovarian cancer
Renal cell carcinoma
Prostate cancer
Breast cancer
Colorectal cancer
Myeloid leukemia
Non-small cell lung cancer
Pancreatic cancer
Head and neck cancer
Squamous cell carcinoma
Mitochondria
Topic: DNA Repair & Metabolism and Cancer Drug Resistance
Topic: Resistance to Cancer Immunotherapy: Mechanisms, Advances, Challenges and Opportunities
Topic: Resistance to Systemic Therapies in Renal Cell Carcinoma
Volume 7
Volume 6, Issue 4
Volume 6, Issue 3
Volume 6, Issue 2
Volume 6, Issue 1
Volume 5, Issue 4
Volume 5, Issue 3
Volume 5, Issue 2
Volume 5, Issue 1
Volume 4, Issue 4
Volume 4, Issue 3
Volume 4, Issue 2
Volume 4, Issue 1
Volume 3, Issue 4
Volume 3, Issue 3
Volume 3, Issue 2
Volume 3, Issue 1
Volume 2, Issue 4
Volume 2, Issue 3
Volume 2, Issue 2
Volume 2, Issue 1
Volume 1, Issue 4
Volume 1, Issue 3
Volume 1, Issue 2
Volume 1, Issue 1
Articles Collection
Related Journals

Extracellular Vesicles and Circulating Nucleic Acids

Editor-in-Chief: Yoke Peng Loh

Journal of Cancer Metastasis and Treatment

The Special Collection "Cancer Cell Plasticity in Therapy Resistance" Officially Launched and Open for Submissions
Interview with Prof. David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment
On November 4, 2024, the editorial team sat down with Prof. David A. Gewirtz, a leading scientist in oncology research and an esteemed member of the journal’s Editorial Board.
Celebrating 48 Editorial Board Members of CDR Named Among the “World’s Top 2% Scientists 2024”
On September 16, 2024, Stanford University and Elsevier jointly released the list of the world’s top 2% scientists.
New Media Partner!
The journal Cancer Drug Resistance has established a media partnership with the European Association for Cancer Research (EACR) and Boehringer Ingelheim for the upcoming EACR-Boehringer Ingelheim Conference: Drugging and Regulating the MAP Kinase Pathway.
Exciting News: Cancer Drug Resistance Journal’s New Impact Factor Reaches 4.6, Ranked in Q1 in Oncology!
We are pleased to announce that our journal, Cancer Drug Resistance (CDR), has obtained a new Impact Factor 2023 of 4.6, as reported by the Journal Citation Reports (JCR) released by Clarivate Analytics on June 20, 2024.
Journal of Cancer Drug Resistance Sees Significant Increase in 2023 CiteScore to 6.6
placing the journal in Q1 in the Pharmacology (medical) discipline

Mitochondria in colorectal cancer stem cells - a target in drug resistance

Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma

P-glycoprotein (ABCB1) - weak dipolar interactions provide the key to understanding allocrite recognition, binding, and transport

Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance

Targeting regulated cell death pathways in acute myeloid leukemia

Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]

NaN
Venetoclax resistance: mechanistic insights and future strategies
Faustine Ong, ... Marina Y. Konopleva
Open Access | Review | 5 May 2022
Views: | Downloads:
Download PDF
Improving HER2 testing reproducibility in HER2-low breast cancer
Elham Sajjadi, ... Nicola FuscoNicola Fusco
Open Access | Opinion | 31 Aug 2022
Views: | Downloads:
Download PDF
Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces
Ahmad R. Safa
Open Access | Review | 1 Aug 2022
Views: | Downloads:
Download PDF

Topic: Innovative Strategies for Overcoming Multidrug Resistance in Breast Cancer

Prof. Kenneth Kin Wah To; Dr. Suresh V. Ambudkar

Submission Deadline: 20 Apr 2025

Published articles: 0

Topic: Exosomes in Combating Cancer Drug Resistance

Dr. Farrukh Aqil; Dr. Ramesh Gupta

Submission Deadline: 15 Apr 2025

Published articles: 0

Related Journals

Extracellular Vesicles and Circulating Nucleic Acids

Editor-in-Chief: Yoke Peng Loh

Journal of Cancer Metastasis and Treatment

Cancer Drug Resistance
ISSN 2578-532X (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2024 OAE Publishing Inc., except certain content provided by third parties